Sitagliptin/Ertugliflozin | Interleukin Related interleukin-related.com

Product Name :
Sitagliptin/Ertugliflozin

Search keywords :
Ertugliflozin L-pyroglutamic acid

drugId :
null

Target Vo:
Dipeptidyl peptidase IV

Target Vo Short Name :
DPP4

Moa_Name:
Sodium/glucose cotransporter 2 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2017

Origin Company_Name :
Pfizer Inc

Active Company_Name :
Merck & Co Inc

Active Indication_Name:
Diabetes Mellitus, Type 2

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Alirocumab PCSK9
BMP2 Antibody In Vivo
ATG4C Antibody: ATG4C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to ATG4C. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts